Objectives: An office-based workup strategy for patients with laryngopharyngeal lesions suspicious for carcinoma is analyzed. The feasibility of office-based transnasal flexible endoscopic biopsies under local anesthesia and the impact on the diagnostic workup are evaluated. Methods: This study is a prospective analysis of patients with laryngeal, oropharyngeal, and hypopharyngeal lesions suspicious for carcinoma. One hundred eighty-eight participants were divided into 2 groups. The first group underwent an office-based biopsy procedure under local anesthesia using a flexible digital video laryngoscope with instrument channel (n = 53), and the second group underwent a biopsy procedure under general anesthesia using rigid laryngopharyngoscopy (n = 135). Results: Office-based flexible endoscopic biopsies were tolerated well, and there were no complications. These biopsies were 92.5% successful in acquiring a definitive diagnosis. Costs were reduced. Diagnostic workup time and time until start of therapy were reduced to 2 days and 27 days, respectively. Conclusion: Office-based biopsy under local anesthesia using flexible digital video laryngoscopy is safe, cost-effective, and successful in providing a histopathological diagnosis. It reduces the diagnostic workup time significantly in patients with laryngeal, oropharyngeal, and hypopharyngeal cancer, while also reducing the necessity to subsequently perform a rigid laryngopharyngoscopy under general anesthesia.
Background
In 2012, the estimated worldwide incidence of laryngeal, oropharyngeal, and hypopharyngeal cancer was 299 264 patients per year, 1 with an estimated 179 481 deaths due to these cancers. 1 Given the increasing incidence of cancer 1 and the rising costs of health care, 2 cost-effectiveness is an increasingly important issue in oncologic care. Moreover, a recent paradigm shift toward patient-centered care is noticeable. Minimizing invasiveness and reducing the time of diagnostic workup fit in this trend. These various issues may be addressed through major improvements in flexible digital endoscopic tools used for assessment of lesions found in the upper aerodigestive tract. In the past decade, several types of transnasal digital video endoscopes (DVEs) have been developed and are being increasingly used in otorhinolaryngological practice. Compared to the traditionally used transnasal fiberoptic laryngoscopes, these digital "chip on tip" video laryngoscopes have tremendously increased visibility of minute detail, but studies have not yet demonstrated an increase in diagnostic accuracy. 3, 4 Flexible laryngoscopes with a working channel can be used to obtain laryngeal and pharyngeal biopsy samples for histopathological examination and to perform several therapeutic procedures, 5 such as endolaryngeal laser surgery and injection of agents. Digital video laryngoscopy also offers the possibility of high-quality visual documentation to allow the sharing of information with other professionals and comparison of lesions over time.
If DVEs are proven to be accurate in determining the extent of laryngopharyngeal carcinoma, are sensitive for detecting second primary tumors in the upper aerodigestive tract, and facilitate office-based flexible endoscopic biopsies (FEBs), rigid laryngopharyngoscopy (RL) under general anesthesia may no longer be necessary in routine diagnostic workup of patients with (lesions suspected for) carcinoma. This will reduce costs, decrease the diagnostic workup time, obviate the need for preoperative consultation of anesthesiologists, and avoid the risks of general anesthesia among patients who often have significant comorbidity and a potentially difficult airway. Furthermore, timely diagnosis and treatment are likely to result in a reduction of uncertainty and anxiety and might improve oncological and functional outcomes.
In this study, we analyzed the success rate of FEB under local anesthesia with DVE with a working channel, among patients with laryngeal, oropharyngeal, and hypopharyngeal lesions suspicious for carcinoma, as well as the diagnostic workup time.
Methods
Patients with clinically suspicious laryngeal, oropharyngeal, and hypopharyngeal lesions were seen in the tertiary Head and Neck Oncology Centre of the Radboud University Medical Center. All patients were examined in a multidisciplinary clinic that included an ear, nose, and throat (ENT)/ head and neck surgeon, a maxillofacial/head and neck surgeon, and a head and neck radiation oncologist. Patients were included if they were referred during 2010 to 2013, if they had a clinically suspicious lesion as judged by the oncological head and neck specialists, and if biopsies of the lesion were obtained in our hospital. Only those who underwent office-based FEB or RL under general anesthesia were included. Patients who were referred to our hospital with conclusive histology or who had undergone transoral biopsy were excluded. Patients were also excluded if additional surgical procedures were planned during RL (eg, tonsillectomy, tracheostomy). Finally, patients with a synchronous second primary tumor and patients who delayed their workup were excluded since this may interfere with the diagnostic workup time and time to treatment.
For eligible patients, FEB under local anesthesia was offered before RL under general anesthesia. When the office-based procedure resulted in a final diagnosis, the RL was canceled. Patients were selected for FEB under local anesthesia if there was a lesion with mucosal involvement, if accurate assessment of the extent of the lesion was possible with transnasal DVE, if the patient was cooperative, and if informed consent was given. Alternatively, the patient underwent RL.
Patients were advised to continue the use of any anticoagulants. If a patient was found suitable for FEB, the procedure was scheduled on the same day as the first clinical visit. During FEB, the patient was placed in an upright and sitting position and was maintained in this position throughout the procedure. Cotton wool pledgets containing lidocaine 10% and xylometazoline 0.1% were inserted intranasally and kept in place for approximately 20 minutes to establish local anesthesia and decongestion of the nasal mucosa. Lidocaine 10% was sprayed transorally. In patients with glottic lesions, an additional 0.5 mL of lidocaine 10% was injected percutaneously through the cricothyroid membrane using a 23-gauge needle on a syringe. As an alternative to this injection, lidocaine was administered through the working channel into the lumen of the larynx of the patient. Rigid laryngopharyngoscopy was performed under general anesthesia. Patients were examined in a state of apnea without intubation.
The DVE used in this study was a flexible video endoscope with working channel (VNL-1570STK; Pentax, Tokyo, Japan). This endoscope has a total diameter of 4.9 mm, with a 2.0-mm-diameter working channel. The endoscope is CE marked. The biopsy forceps used is a single-use 1.8-mm-diameter forceps with needle (Radial Jaw 4, pulmonary standard capacity with needle, standard 2.0 mm; Boston Scientific, Heredia, Costa Rica).
An initial biopsy was considered successful when the histological examination was representative of the clinical aspect of the tumor, for example, in histopathological outcome of carcinoma in situ/severe dysplasia (CIS) or squamous cell carcinoma (SCC) in a high clinical suspicion of malignancy. In case of uncertainty about the histological outcome, additional biopsies were performed.
Costs for RL and FEB were based on the purchase, depreciation, and sterilization of the equipment; the costs of disposables; salary of involved medical employees; and institutional rates for daycare. We used an average rate based on average procedure time and did not include the cost associated with unforeseen increased procedure time.
Diagnostic workup time was defined as the number of days from the initial consultation in the outpatient clinic until the date of the multidisciplinary head and neck tumor board meeting, during which the final tumor stage was assigned and the treatment plan was established. In our center, results of imaging and cytological and histological examination are completed within 1 to 2 days. The time to treatment was defined as the number of days from the initial consultation in the outpatient clinic until the date of surgery or first fraction of radiotherapy.
Statistical Analysis
Statistical analysis was performed using SPSS Statistics 20. Results were tested with 1-way analysis of variance. For continuous outcome variables that were not normally distributed, Mann-Whitney U tests were used. For discrete outcome variables, chi-square tests were used and, only in case where conditions were not met, a Fisher exact test. The significance level was set at P ⩽ .05. In benign lesions, follow-up time was the reference for the final diagnosis.
Results
From 2010 until 2013, 1925 new patients were referred to our Head and Neck Oncologic Center, and 910 of them had a laryngeal, oropharyngeal, or hypopharyngeal tumor. Patients referred with conclusive histology or those who underwent transoral biopsy in our outpatient clinic were excluded (n = 609). A further 104 patients were excluded because the RL was performed during additional surgical procedures. In addition, 9 patients were excluded for other reasons. In total, 188 patients with a laryngeal, oropharyngeal, or hypopharyngeal tumor underwent a biopsy in our center, with either RL or FEB. Fifty-three patients (28.2%) underwent FEB with transnasal DVE, and 135 patients (71.8%) underwent RL and biopsy. The percentage of FEB during the study period increased from an initial 2.6% in 2010 to 45.7% in 2013. Patient characteristics are summarized in Table 1 .
All patients who underwent FEB tolerated the procedure well. There were no complications related to the FEB or the RL procedure. Initial taken FEB was successful in confirming definitive diagnosis in 49 of the 53 patients (92.5%). Two of these 49 patients had benign disease. Tumor stage (T stage) had no influence on the diagnostic success rate. FEB was 100% diagnostic in all areas except the supraglottic subsite. In FEB, the median number of biopsies per patient was 3. The second group, consisting of 135 patients, underwent an RL under general anesthesia, with an initial success rate of 91.1%. Site-specific success percentages are summarized in Table 2 .
We found a positive predictive value (PPV) of 100% of initial FEB showing CIS or SCC, based on matching clinical aspect of the lesion compared to histopathological outcome of FEB. In 30 of these 47 patients, the diagnosis was confirmed with formal histopathology after ablative surgical treatment, lymphogenic metastasis (fine needle aspiration cytology or histopathology), and/or histologically proven recurrent disease. The negative predictive value (NPV) of initial FEB was only 33%. In the FEB group, 2 patients had benign lesions, and in 4 patients, initial FEB was nondiagnostic. Of these 4 patients with a nondiagnostic initial FEB, 1 underwent a second FEB, 1 had a subsequent RL, and the remaining 2 patients had cytological puncture of lymph node(s) confirming the diagnosis of SCC. The average cost per procedure were €87.95 for FEB and €821.58 for RL. Specifications of the cost per procedure are summarized in Table 3 . When the cost for additional diagnostic procedures in initial nondiagnostic procedure is included, average cost per patient in the FEB group was €105.11 and in the RL group €864.83.
Median diagnostic workup time of FEB was 2 days, defined as the number of days between initial consultation and the date of the multidisciplinary head and neck tumor board meeting. The 25th and 75th percentiles were both 2 days. Figure 1 shows a box plot of the distribution of the diagnostic workup time in days. In addition, median duration from initial contact until start of treatment in patients who underwent FEB under local anesthesia was 27 days. The interquartile range (IQR) (ie, the 75th percentile minus the 25th percentile) was 13 days. Figure 2 shows a box plot of the distribution of time to treatment in days.
In RL, diagnostic workup time and time to treatment were longer, with 16 days (IQR, 14) and 41.5 days (IQR, 16), respectively. Both diagnostic workup time and time to treatment were significantly decreased in FEB compared to RL (P < .0001 and P < .0001, respectively).
Discussion
In our study, transnasal flexible endoscopic laryngopharyngeal biopsies under local anesthesia in an office-based setting were well tolerated, fast and without complications, and highly successful in providing a swift histopathological confirmation of the presence of cancer. We found a high level of success in establishing a definitive diagnosis after initial biopsies in FEB under local anesthesia of 92.5%. The diagnostic workup time and time to treatment were 2 and 27 days, respectively. Previous studies have shown variable success rates [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] but a similar high tolerance of FEB. Naidu et al 7 and Cohen and Benyamini 8 reported in-office biopsies to be diagnostic in 64% and 68.8%, respectively. In the former study, 58% of the patients underwent additional biopsy under general anesthesia. 7 In the latter study, after performing in-office biopsies with a fiberoptic laryngoscope, all patients with benign lesions or carcinoma in situ subsequently underwent laryngoscopy under general anesthesia. 8 The authors also found a PPV of a pathology result of fiberoptic biopsies of 98% and an NPV of 57% when compared to direct laryngoscopy biopsies. 8 Cha et al 9 studied 581 laryngeal lesions and found a PPV and NPV for malignancy in FEB of 100% and 87.3%, respectively. More than half of the patients included had benign lesions. 9 Comparable to our study, Castillo Farías et al 10 also selected patients with pharyngolaryngeal lesions suspicious for malignancy. All patients underwent FEB and subsequent biopsies performed with RL. They found an NPV in FEB of 20%. In our study, we did not routinely perform subsequent RL after FEB. After the establishment of the histopathologic diagnosis using an office-based approach, we deemed it unethical to perform a further investigation under general anesthesia with its associated morbidity. In 30 patients who underwent FEB, the diagnosis was confirmed with formal histopathology after ablative surgical treatment, lymphogenic metastasis (fine needle aspiration cytology or histopathology), and/or histologically proven recurrent disease. Thereby, a PPV of 100% in these patients was confirmed. We did find a low NPV in FEB (33%). This low NPV is likely to be the result of our selection of patients with a high clinical suspicion of malignancy. Given this fact, where initial biopsies are negative, repeated biopsies should be pursued.
Histopathology of the patients with laryngopharyngeal lesions obtained by initial FEB revealed SCC in 40 of the 51 patients (78.4%) and CIS in 7 patients (13.7%); it was nondiagnostic in the remaining 4 patients (7.8%). All 7 CISs were eventually staged as T1 to T3 SCC by the multidisciplinary tumor board based on positive fine needle aspiration of a cervical lymph node (n = 3), high suspicion of invasive carcinoma in histopathology combined with the convincing clinical aspect of the tumor (n = 2), and the convincing clinical aspects of the tumor (n = 2; both T2 carcinoma). The differences in success may be explained by differences in patient selection, use of adequate local anesthesia for the office-based procedure, the number of biopsies taken, and perhaps the skill of the performing physician. Especially in biopsies of the glottic mucosa, good local anesthesia is essential for a successful biopsy procedure. Laryngeal lesions consisted of only 11.7% of the study cohort. This low percentage is likely the result of our current treatment protocol for limited glottis lesions. All patients with dysphonia and limited glottic lesions with suspicion of malignancy, if suitable, underwent transoral laser microsurgery with therapeutic resection of the lesion without prior diagnostic biopsy. All 53 patients tolerated the FEB. Other studies found tolerance ranging from 91.7% to 100%. 7, 8, [10] [11] [12] 15 Our median number of biopsies taken during one procedure was 3. The low NPV of FEB found by Cohen and Benyamini 8 might be associated with the number of biopsies taken. They describe having to take more than 1 biopsy in some cases, implying that 1 biopsy was taken in most cases. Richards et al 13 took 81 biopsies in 76 patients. Lippert et al 11 did not mention the number of biopsies that were taken. We found a probability of establishing the diagnosis of carcinoma if 2 or 3 biopsies were taken, with 90.9% and 95.0%, respectively, of all patients with a histopathologically proven biopsy. Although the available data were insufficient for analyzing the number of biopsies needed for a definitive diagnosis, biopsies were more likely to contain carcinoma if the physician considered them as representative for the lesion. Furthermore, a dedicated team was important for a successful procedure. We experienced a learning curve in successfully performing office-based biopsies. With growing experience, our inclusion criteria expanded and the proportion of patients undergoing FEB increased from 2.6% in 2010 to 45.7% in 2013. In addition, the duration of the procedure was reduced from 30 minutes to less than 5 minutes. All of the factors mentioned above have led to an increase in FEB performed in our center. Currently, we perform diagnostic RL only in those patients who do not cooperate with DVE, if accurate assessment of the extent of the tumor with DVE is impossible, and for patients with submucosal lesions. When initial FEB was insufficient, in 4 of 53 patients, a second FEB or RL with biopsy under general anesthesia was performed based on previous experience with FEB in the specific case. This may explain the outliers shown in Figure 1 .
There were no complications, specifically no bleeding, even though continuation of anticoagulant use was allowed. Absence of major complications in office-based biopsies [8] [9] [10] [11] [12] [13] [14] [15] [16] 18 and surgery with continuation of anticoagulants, including Coumadin, 17 are in line with other reports in the literature.
Another advantage is that patients, often with significant comorbidity, may be spared the risks of general anesthesia by moving the diagnostic process to the outpatient setting. Moreover, this shift reduces costs. In our clinic, the average cost for an FEB under local anesthesia was nearly 90% less (€733.63) than the cost for an RL in general anesthesia. Multiple studies have shown significantly lowered costs of office-based biopsies compared to biopsies under general anesthesia. 7, 9, 10, 19 In our clinic, we have been trying to reduce the diagnostic oncologic workup time for several years, but waiting time for RL as part of the diagnostic procedures remained one of the main obstacles. The introduction of DVE and FEB as an interim step before performing routine RL resulted in a further reduction in diagnostic workup time, thereby increasing the efficiency of workup among head and neck patients. Diagnostic workup time is currently 2 days. Lippert et al 11 found time to treatment was 24.2 days in successful FEB compared to 48.8 days when unsuccessful. Our time to treatment was 27 days in FEB as compared to 41.5 days in RL (P < .0001).
Numerous articles have been published on the occurrence of multiple primary malignant neoplasms among patients with head and neck cancer. Chuang et al 20 studied 99 257 patients with primary cancers of the oral cavity, oropharynx, hypopharynx, or larynx and found a synchronous second primary tumor in the oropharynx or hypopharynx in 0.41% of patients, in the larynx in 0.19% of patients, in the esophagus in 0.58% of patients, and in the lung of 3.38% of patients. If RL is eventually substituted with DVE in an outpatient clinic setting, it could be argued that detection of second primary tumors in the aerodigestive tract may be hampered. Further studies will be needed to assess this. However, the clarity and detail provided by DVE image-enhancing filters may potentially contribute to the detection of even small lesions, and the possibility of digital transnasal esophagoscopy is likely to be a good alternative for routine diagnostic panendoscopy under general anesthesia.
A selection bias was introduced as patients were not randomized, and strict inclusion criteria for FEB under local anesthesia were applied. First, tumor boundaries had to be clear on transnasal flexible laryngopharyngoscopy. As DVE provides much more detail of the mucosa as compared to fiberoptic laryngoscopes, tumor boundaries can be defined in the majority of patients. However, we are not aware of studies comparing determination of tumor boundaries found with DVE to those found with RL. Second, the otorhinolaryngologist/head and neck surgeon must assess which patients are likely to be able to undergo FEB. This decision is based on the patients' ability to endure routine transnasal laryngopharyngoscopy, but judgments may differ. However, the question remains if FEB has to be compared with RL in general anesthesia or should be implemented as an addition to the armamentarium of the physician.
Conclusion
In this study, biopsies under local anesthesia using transnasal flexible digital video laryngoscopes were safe and well tolerated, showed high initial diagnostic accuracy, and had a significant reduction of the diagnostic workup time and subsequent time to treatment. In suspected laryngeal, oropharyngeal, and hypopharyngeal carcinoma, office-based FEB offers a good diagnostic tool and, in selected cases, makes performing RL redundant.
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